191 related articles for article (PubMed ID: 2472471)
1. Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma.
Rustin GJ; Newlands ES; Begent RH; Dent J; Bagshawe KD
J Clin Oncol; 1989 Jul; 7(7):900-3. PubMed ID: 2472471
[TBL] [Abstract][Full Text] [Related]
2. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
3. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
Newlands ES
Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral hemorrhage as initial presentation of gestational choriocarcinoma: a case report and literature review.
Huang CY; Chen CA; Hsieh CY; Cheng WF
Int J Gynecol Cancer; 2007; 17(5):1166-71. PubMed ID: 17425677
[TBL] [Abstract][Full Text] [Related]
5. Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.
Hiramatsu Y; Masuyama H; Ishida M; Murakami K; Sakurai M
Acta Med Okayama; 2005 Oct; 59(5):235-8. PubMed ID: 16286962
[TBL] [Abstract][Full Text] [Related]
6. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
Lurain JR; Schink JC
J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
[TBL] [Abstract][Full Text] [Related]
7. Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature.
Behtash N; Behnamfar F; Hamedi B; Ramezanzadeh F
Arch Gynecol Obstet; 2009 Apr; 279(4):579-81. PubMed ID: 18726607
[TBL] [Abstract][Full Text] [Related]
8. Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome.
Savage P; Kelpanides I; Tuthill M; Short D; Seckl MJ
Gynecol Oncol; 2015 Apr; 137(1):73-6. PubMed ID: 25598530
[TBL] [Abstract][Full Text] [Related]
9. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
10. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
11. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.
Lybol C; Thomas CM; Blanken EA; Sweep FC; Verheijen RH; Westermann AM; Boere IA; Reyners AK; Massuger LF; van Hoesel RQ; Ottevanger PB
Eur J Cancer; 2013 Mar; 49(4):860-7. PubMed ID: 23099004
[TBL] [Abstract][Full Text] [Related]
12. Postpartum choriocarcinoma complicated by brain and lung metastases treated successfully with EMA/CO regimen.
Nozue A; Ichikawa Y; Minami R; Tsunoda H; Nishida M; Kubo T
BJOG; 2000 Sep; 107(9):1171-2. PubMed ID: 11002965
[No Abstract] [Full Text] [Related]
13. Gestational choriocarcinoma.
Bower M; Brock C; Fisher RA; Newlands ES; Rustin GJ
Ann Oncol; 1995 May; 6(5):503-8. PubMed ID: 7669714
[No Abstract] [Full Text] [Related]
14. Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Fujisawa M
Int J Urol; 2010 Oct; 17(10):881-5. PubMed ID: 20731738
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol].
Fechtig A; de Dycker RP; Schumacher T; Zajaczkowski T; Neumann RL
Geburtshilfe Frauenheilkd; 1992 Apr; 52(4):235-8. PubMed ID: 1607119
[TBL] [Abstract][Full Text] [Related]
16. Improvement in survival from choriocarcinoma in Harare.
Spooner SF; Coulombier DM
Cent Afr J Med; 1991 Aug; 37(8):229-34. PubMed ID: 1725504
[TBL] [Abstract][Full Text] [Related]
17. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
Mao Y; Wan X; Lv W; Xie X
Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
[TBL] [Abstract][Full Text] [Related]
18. Metastatic cerebral choriocarcinoma coexistent with a viable pregnancy.
Dana A; Saldanha GJ; Doshi R; Rustin GJ
Gynecol Oncol; 1996 Apr; 61(1):147-9. PubMed ID: 8626104
[TBL] [Abstract][Full Text] [Related]
19. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
20. Pegylated Liposomal Doxorubicin Is an Active Agent for Chemotherapy-Resistant Choriocarcinoma: A Report of Two Cases.
Popadiuk C; Power P
J Reprod Med; 2016; 61(5-6):215-8. PubMed ID: 27424361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
